XETRA

AI 'Brain' Technology by Rezolve Joins Forces with NAGA to Revolutionise Online Payment together with Brokerage Transformation

Retrieved on: 
Wednesday, August 9, 2023

This multilingual capacity not only enhances NAGA user experience but also widens NAGA's global user base.

Key Points: 
  • This multilingual capacity not only enhances NAGA user experience but also widens NAGA's global user base.
  • Implementing Brain's AI into NAGA will further automate our client's journey and lead to the highest degree in personalization.
  • Dan Wagner, CEO of Rezolve , echoed this sentiment, adding, "Our collaboration with NAGA is a testament to our commitment to revolutionising industries with AI.
  • For more information about NAGA and its use of Rezolve's Brain, which is expected to go live in Q4 2023, please visit www.group.naga.com

The NAGA Group AG: AI 'Brain' Technology by Rezolve Joins Forces with NAGA to Revolutionise Online Payment together with Brokerage Transformation

Retrieved on: 
Wednesday, August 9, 2023

Implementing 'Brain’s AI into NAGA will further automate our client’s journey and lead to the highest degree in personalization.

Key Points: 
  • Implementing 'Brain’s AI into NAGA will further automate our client’s journey and lead to the highest degree in personalization.
  • Users will intuitively understand NAGA social trading platform and their own trading performance better than ever before.
  • Dan Wagner, CEO of Rezolve, echoes this sentiment, adding, "Our collaboration with NAGA is a testament to our commitment to revolutionising industries with AI.
  • For more information about NAGA and its use of Rezolve's 'Brain', which is expected to go live in Q4 2023, please visit www.group.naga.com .

EQS-News: The NAGA Group AG: AI 'Brain' Technology by Rezolve Joins Forces with NAGA to Revolutionise Online Payment together with Brokerage Transformation

Retrieved on: 
Wednesday, August 9, 2023

Implementing 'Brain’s AI into NAGA will further automate our client’s journey and lead to the highest degree in personalization.

Key Points: 
  • Implementing 'Brain’s AI into NAGA will further automate our client’s journey and lead to the highest degree in personalization.
  • Dan Wagner, CEO of Rezolve, echoes this sentiment, adding, "Our collaboration with NAGA is a testament to our commitment to revolutionising industries with AI.
  • The introduction of Rezolve’s 'Brain' into NAGA social trading platform marks an exciting development in the fintech sector, as AI and human insights converge to offer superior multilingual trading experiences.
  • For more information about NAGA and its use of Rezolve's 'Brain', which is expected to go live in Q4 2023, please visit www.group.naga.com.

AI 'Brain' Technology by Rezolve Joins Forces with NAGA to Revolutionise Online Payment together with Brokerage Transformation

Retrieved on: 
Wednesday, August 9, 2023

This multilingual capacity not only enhances NAGA user experience but also widens NAGA's global user base.

Key Points: 
  • This multilingual capacity not only enhances NAGA user experience but also widens NAGA's global user base.
  • Implementing Brain's AI into NAGA will further automate our client's journey and lead to the highest degree in personalization.
  • Dan Wagner, CEO of Rezolve , echoed this sentiment, adding, "Our collaboration with NAGA is a testament to our commitment to revolutionising industries with AI.
  • For more information about NAGA and its use of Rezolve's Brain, which is expected to go live in Q4 2023, please visit www.group.naga.com

EQS-News: OHB SE: OHB strengthens capital base to implement corporate strategy, Fuchs family remains long term majority shareholder

Retrieved on: 
Monday, August 7, 2023

OHB SE: OHB strengthens capital base to implement corporate strategy, Fuchs family remains long term majority shareholder

Key Points: 
  • OHB SE: OHB strengthens capital base to implement corporate strategy, Fuchs family remains long term majority shareholder
    The issuer is solely responsible for the content of this announcement.
  • OHB strengthens capital base to implement corporate strategy, Fuchs family remains long term majority shareholder
    KKR plans voluntary public takeover offer for all outstanding shares of OHB at a price of EUR 44.00, the Fuchs family will not sell any shares
    Bremen, 7th August, 2023.
  • To this end, OHB has today signed, amongst others, an investment agreement with KKR and the Fuchs Family Foundation as the majority shareholder of OHB, as well as with investment vehicles controlled by the Fuchs family.
  • Marco Fuchs, CEO of OHB: “Strengthening OHB as an independent, European company and partner for governments and institutions strengthens European security and sovereignty in space.

Newron Announces H1 2023 Results and Provides R&D Update

Retrieved on: 
Friday, August 4, 2023

We have reported three striking sets of data from our evenamide development program for treatment-resistant schizophrenia (TRS), presented these results at international psychiatry scientific conferences, and published key results in a peer-reviewed journal.

Key Points: 
  • We have reported three striking sets of data from our evenamide development program for treatment-resistant schizophrenia (TRS), presented these results at international psychiatry scientific conferences, and published key results in a peer-reviewed journal.
  • The exciting results triggered substantial interest from potential partners on future collaboration opportunities for the development of evenamide.”
    In Q1 2023, Newron announced three exciting new sets of data evaluating evenamide as an add-on treatment for patients with TRS.
  • Study 008A is continuing to enroll patients in this indication, and results are expected by end of 2023/early in 2024.
  • Financial Summary (IFRS) H1 2023 and H1 2022:

EQS-News: Newron announces H1 2023 results and provides R&D update

Retrieved on: 
Friday, August 4, 2023

We have reported three striking sets of data from our evenamide development program for treatment-resistant schizophrenia (TRS), presented these results at international psychiatry scientific conferences, and published key results in a peer-reviewed journal.

Key Points: 
  • We have reported three striking sets of data from our evenamide development program for treatment-resistant schizophrenia (TRS), presented these results at international psychiatry scientific conferences, and published key results in a peer-reviewed journal.
  • Study 008A is continuing to enroll patients in this indication, and results are expected by end of 2023/early in 2024.
  • The results seen validate the rule of glutamate release inhibition in repairing disturbed neural connectivity in the TRS population.
  • Financial Summary (IFRS) H1 2023 and H1 2022:

EQS-News: Advanced Blockchain AG publishes audited consolidated financial statements

Retrieved on: 
Wednesday, August 2, 2023

August 2023 - Advanced Blockchain AG ("AB," Scale Frankfurt, Primary Market Düsseldorf, XETRA: ISIN DE000A0M93V6), a leading incubator, architect, and investor in the blockchain industry, today announces the publication of its audited consolidated financial statements for the year 2022.

Key Points: 
  • August 2023 - Advanced Blockchain AG ("AB," Scale Frankfurt, Primary Market Düsseldorf, XETRA: ISIN DE000A0M93V6), a leading incubator, architect, and investor in the blockchain industry, today announces the publication of its audited consolidated financial statements for the year 2022.
  • Despite the challenging market environment, Advanced Blockchain AG recorded a continuous and stable development in 2022.
  • As expected, revenue reached of EUR 14.9 million and consolidated net profit amounted to EUR 1.9 million.
  • In the current 2023 financial year, Advanced Blockchain's management focus is on sustainable growth and cost reduction.

EQS-News: ParTec AG: Shares also tradable on Xetra as of today 

Retrieved on: 
Tuesday, August 1, 2023

By listing its shares on Xetra, ParTec is positioning itself even more broadly on the capital market and increasing its visibility among international investors.

Key Points: 
  • By listing its shares on Xetra, ParTec is positioning itself even more broadly on the capital market and increasing its visibility among international investors.
  • It is also intended to increase the overall liquidity of trading in ParTec shares.
  • Since July 3rd 2023, ParTec AG shares have been listed in the Scale segment of the Frankfurt Stock Exchange.
  • Bernhard Frohwitter, CEO of ParTec AG based in Munich: "With the listing on Xetra, ParTec takes another important step on its growth path.

EQS-News: init innovation in traffic systems SE: Status of the share buyback: 10 July to 14 July 2023

Retrieved on: 
Tuesday, July 18, 2023

init innovation in traffic systems SE: Status of the share buyback: 10 July to 14 July 2023

Key Points: 
  • init innovation in traffic systems SE: Status of the share buyback: 10 July to 14 July 2023
    The issuer is solely responsible for the content of this announcement.
  • In the period from 10 July to 14 July 2023, init innovation in traffic systems SE (ISIN DE0005759807) acquired 3,248 treasury shares at a value of EUR 100,521.22.
  • The acquisition was carried out by the assigned bank via the stock exchange (XETRA).
  • Information about individual transactions and daily trading volumes is published online under the following link: